105 related articles for article (PubMed ID: 21564073)
1. The association between porphyria cutanea tarda and diabetes mellitus: analysis of a long-term follow-up cohort.
Muñoz-Santos C; Guilabert A; Moreno N; Gimenez M; Darwich E; To-Figueras J; Herrero C
Br J Dermatol; 2011 Sep; 165(3):486-91. PubMed ID: 21564073
[TBL] [Abstract][Full Text] [Related]
2. Screening of patients with iron overload to identify hemochromatosis and porphyria cutanea tarda.
O'Reilly FM; Darby C; Fogarty J; Tormey W; Kay EW; Leader M; Murphy GM
Arch Dermatol; 1997 Sep; 133(9):1098-101. PubMed ID: 9301586
[TBL] [Abstract][Full Text] [Related]
3. Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection.
Martinelli AL; Zago MA; Roselino AM; Filho AB; Villanova MG; Secaf M; Tavella MH; Ramalho LN; Zucoloto S; Franco RF
Am J Gastroenterol; 2000 Dec; 95(12):3516-21. PubMed ID: 11151887
[TBL] [Abstract][Full Text] [Related]
4. Increased serum hepcidin levels in patients with porphyria cutanea tarda.
Darwich E; To-Figueras J; Molina-López RA; Deulofeu R; Olbina G; Westerman M; Sánchez-Tápias JM; Muñoz-Santos C; Herrero C
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e68-74. PubMed ID: 22429447
[TBL] [Abstract][Full Text] [Related]
5. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients.
Dabrowska E; Jabłońska-Kaszewska I; Bielawski KP; Falkiewicz B
Med Sci Monit; 2001 May; 7 Suppl 1():190-6. PubMed ID: 12211718
[TBL] [Abstract][Full Text] [Related]
6. Effects of vitamin E administration on the hemorheological status and redox homeostasis of patients with porphyria cutanea tarda treated with phlebotomy.
Székely E; Vereckei A; Almási A; Rapavi E; Tasnádi G; Várnai K; Pallai Z; Lugasi A; Blázovics A
Clin Hemorheol Microcirc; 2007; 36(1):13-23. PubMed ID: 17211058
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of hepatitis C virus type 1b in Italian patients with Porphyria cutanea tarda.
Sampietro M; Fracanzani AL; Corbetta N; Amato M; Mattioli M; Molteni V; Fiorelli G; Fargion S
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):543-7. PubMed ID: 9513830
[TBL] [Abstract][Full Text] [Related]
8. Porphyria cutanea tarda in a Swedish population: risk factors and complications.
Rossmann-Ringdahl I; Olsson R
Acta Derm Venereol; 2005; 85(4):337-41. PubMed ID: 16191856
[TBL] [Abstract][Full Text] [Related]
9. Iron and porphyria cutanea tarda.
D'Alessandro Gandolfo L; Griso D; Macrì A; Biolcati G; Barlattani A; Topi GC
Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):75-9. PubMed ID: 9074791
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of hepatitis C and G in sporadic and familial porphyria cutanea tarda.
Lamoril J; Andant C; Bogard C; Puy H; Gouya L; Pawlotsky JM; Da Silva V; Soulé JC; Deybach JC; Nordmann Y
Hepatology; 1998 Mar; 27(3):848-52. PubMed ID: 9500716
[TBL] [Abstract][Full Text] [Related]
11. Hemorheological status and redox homeostasis of phlebotomised porphyria cutanea tarda patients with diabetes mellitus and in moderate alcohol consumer.
Székely E; Bor M; Tasnádi G; Várnai K; Almási A; Blázovics A
Clin Hemorheol Microcirc; 2006; 35(3):387-96. PubMed ID: 16899961
[TBL] [Abstract][Full Text] [Related]
12. Effect of high fiber vegetable-fruit diet on the activity of liver damage and serum iron level in porphyria cutanea tarda (PCT).
Dabrowska E; Jabłońska-Kaszewska I; Falkiewicz B
Med Sci Monit; 2001 May; 7 Suppl 1():282-6. PubMed ID: 12211737
[TBL] [Abstract][Full Text] [Related]
13. [Determination of serum ferritin in porphyria cutanea tarda. A reliable sign of hepatic siderosis].
Gibertini P; Rocchi E; Cassanelli M; Pietrangelo A; Coppini M; Ventura E
Minerva Med; 1984 Mar; 75(9-10):469-74. PubMed ID: 6709223
[TBL] [Abstract][Full Text] [Related]
14. Porphyria cutanea tarda, hepatitis C virus and selected symptoms of cholestasis.
Dabrowska E; Jabłońska-Kaszewska I; Bielawski KP; Podlaska M; Falkiewicz B
Med Sci Monit; 2001 May; 7 Suppl 1():185-9. PubMed ID: 12211717
[TBL] [Abstract][Full Text] [Related]
15. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.
Siersema PD; Rademakers LH; Cleton MI; ten Kate FJ; de Bruijn WC; Marx JJ; Wilson JH
J Hepatol; 1995 Sep; 23(3):259-67. PubMed ID: 8550989
[TBL] [Abstract][Full Text] [Related]
16. [Serum lipoproteins in patients with porphyria cutanea tarda].
Fernández-Miranda C; de la Calle M; Gómez Izquierdo MT; Larumbe S; Enríquez de Salamanca R
Med Clin (Barc); 1999 May; 112(17):656-7. PubMed ID: 10374187
[TBL] [Abstract][Full Text] [Related]
17. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
Gamberini MR; De Sanctis V; Gilli G
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():158-69. PubMed ID: 19337172
[TBL] [Abstract][Full Text] [Related]
18. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda].
Malina L; Zd'árský E; Dandová S; Michalíková H; Cerná M; Cimburová M
Cas Lek Cesk; 2000 Nov; 139(23):728-30. PubMed ID: 11191743
[TBL] [Abstract][Full Text] [Related]
19. Molecular heterogeneity of familial porphyria cutanea tarda in Spain: characterization of 10 novel mutations in the UROD gene.
Méndez M; Poblete-Gutiérrez P; García-Bravo M; Wiederholt T; Morán-Jiménez MJ; Merk HF; Garrido-Astray MC; Frank J; Fontanellas A; Enríquez de Salamanca R
Br J Dermatol; 2007 Sep; 157(3):501-7. PubMed ID: 17627795
[TBL] [Abstract][Full Text] [Related]
20. Deferasirox for porphyria cutanea tarda: a pilot study.
Pandya AG; Nezafati KA; Ashe-Randolph M; Yalamanchili R
Arch Dermatol; 2012 Aug; 148(8):898-901. PubMed ID: 22911183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
